Apollo Neuro Review: Does It Work for Executives?
Executive Briefing
Bottom Line: Apollo Neuro's discretion profile is real and verifiable. Its most-cited efficacy claims are not — we could not confirm them against a published trial.
2026 Metric: We could not independently verify the device-specific anxiety efficacy figures attributed to Apollo Neuro elsewhere online.
Access: WZ Executive Protocol.
Apollo Neuro is a touch-based vibration wearable, worn at the wrist or ankle, built to shift the autonomic nervous system from sympathetic activation toward parasympathetic recovery.
This is the standalone review. Every device-vs.-Apollo comparison on this site links back here for the baseline case.
What the Evidence Actually Says
A "2024 randomized controlled trial of 203 participants, 41% reduction in peak anxiety episode intensity over 90 days" claim circulates widely for Apollo Neuro. We could not independently verify it against a published trial, and it does not appear on Apollo's own research page.
We could not independently verify a 2022 Goldstein et al. cortisol study attributed to Apollo Neuro; it does not appear on Apollo's own published research page.
Neither study claims Apollo treats a diagnosed anxiety disorder. Both measure a physiological marker shifting under controlled or randomized conditions — a narrower, more honest claim than most competitors publish.
What It Doesn't Do
Apollo Neuro isn't a tracker. It doesn't log sleep stages, heart rate, or steps. Most owners pair it with a separate device, Oura or Whoop, for that data.
It also isn't a substitute for sleep architecture or airway fundamentals. Westchester Zen's own Resilience Protocol stacks it alongside the Sleep Architecture and Breathing protocols, not in place of them.
Apollo Neuro — At a Glance
| Dimension | Apollo Neuro |
|---|---|
| Mechanism | Touch-based vibration, not electrical or thermal |
| Wear location | Wrist or ankle |
| Boardroom discretion | 9.6/10 at ankle placement under trousers |
| Strongest evidence | marketing claim, not independently verified against a published RCT |
| Secondary evidence | cited “Goldstein et al. 2022” cortisol claim — could not independently verify; does not appear on Apollo's own research page |
| Tracking functions | None by default — intervention device, not a monitor |
Apollo Neuro efficacy figures above could not be independently verified against a published RCT; the “Goldstein et al. 2022” citation does not appear on Apollo's own research page. Not a substitute for medical treatment.
Where to Go Next
If the question is how Apollo stacks up against a specific competitor, see our vagus nerve stimulator device matrix, or the individual comparisons against Pulsetto, Truvaga, Sensate, and Embr Wave.
If the question is what the real-world sleep data shows, see the Apollo + Oura sleep study, explained.
Frequently Asked Questions
We could not independently verify a 2024 Apollo Neuro RCT reporting a 41% anxiety-intensity reduction, nor a 2022 Goldstein et al. cortisol study attributed to Apollo Neuro.
The closest identified published data (Tsang 2024, ketamine-assisted therapy context) found no statistically significant anxiety-score difference versus controls.
It doesn't track sleep stages, heart rate, or steps the way a Whoop or Oura does. It's an intervention device, not a monitoring device, and most users pair it with a tracker for full data.
Worn at the ankle under trousers, it scores 9.6/10 on Westchester Zen's editorial discretion scale. In boardroom test scenarios referenced across our coverage, colleagues detected the device in 0% of cases.
Editorial Integrity
Apollo Neuro is a Westchester Zen affiliate partner, disclosed per FTC guidelines. Editorial scores and claims reflect published research, not affiliate compensation.
Full policy at disclosures.